ALBUQUERQUE, NM--(Marketwired - Feb 2, 2016) - After an extensive device trial conducted by Dr. Farhan Taghizadeh at New Mexico Facial Plastics, the FDA approved the Vivace microneedling with radio frequency device in January 2016.
"Vivace combines targeted micro-needling with radio-frequency (electrical) energy to help stimulate and tighten the skin even in the deepest layers," said Dr. Taghizadeh, a double board-certified ENT and Facial Plastic and Reconstructive surgeon. "Vivace microneedling can be used on almost any area of the face or body and any skin type, and is especially helpful in reducing acne scarring."
Vivace microneedling with radio frequency involves the placement of a handheld device over the area of skin to be treated, which activates the radio frequency energy. The handpiece consists of a multiple needle head that is targeted to a specified depth depending on each patient's desired result. The patient's skin is numbed prior to treatment to ensure maximum comfort.
When these tiny needles puncture the skin, they produce very tiny "wounds" that stimulate new collagen formation in the skin, as well as the production of hyaluronic acid and elastin, both skin-tightening agents. The result is healthier, plumper and younger-looking skin.
Vivace microneedling helps improve the appearance of:
- Fine lines/ Wrinkles
- Pore size
- Overall Skin Rejuvenation
- Acne Scarring
It's recommended that patients undergo between 3 and 6 sessions spread approximately 1 week apart with regular maintenance treatments afterward. Each treatment takes about an hour. The benefits include smaller pore size, reduced secretion of skin oils (seborrhea), minimized appearance of fine lines and wrinkles, improved delivery and absorption of medical-grade skin care products, and reduced occurrence of acne.
To maximize the effectiveness of Vivace, patients can combine it with platelet-rich plasma (PRP) as the two treatments complement each other. Vivace helps the PRP to easily penetrate the skin for maximum results.